We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
101
Encompass Health
EHC
$12.4B
$5.13M 0.18%
77,909
-27,842
-26% -$1.64M
YMAB
102
DELISTED
Y-mAbs Therapeutics
YMAB
$5M 0.18%
100,994
+6,427
+7% +$297K
AZTA icon
103
Azenta
AZTA
$1.51B
$4.93M 0.17%
72,598
-25,524
-26% -$1.59M
GLUU
104
DELISTED
Glu Mobile Inc.
GLUU
$4.77M 0.17%
529,848
-121,717
-19% -$1.05M
ITRN icon
105
Ituran Location and Control
ITRN
$1.04B
$4.65M 0.16%
244,259
+3,663
+2% +$59.2K
ZWS icon
106
Zurn Elkay Water Solutions
ZWS
$8.48B
$4.6M 0.16%
241,723
-86,306
-26% -$1.48M
CALY
107
Callaway Golf Company
CALY
$3.07B
$4.57M 0.16%
190,163
-66,387
-26% -$1.35M
VRNT
108
DELISTED
Verint Systems
VRNT
$4.41M 0.16%
128,895
-45,005
-26% -$1.28M
CVET
109
DELISTED
Covetrus, Inc. Common Stock
CVET
$4.4M 0.15%
153,188
-54,174
-26% -$1.46M
ICFI icon
110
ICF International
ICFI
$1.67B
$4.39M 0.15%
59,107
-20,732
-26% -$1.49M
AKBA icon
111
Akebia Therapeutics
AKBA
$234M
$4.33M 0.15%
1,546,169
-32,910
-2% -$96.1K
OPTN
112
DELISTED
OptiNose
OPTN
$4.3M 0.15%
69,201
-731
-1% -$44.8K
NUVA
113
DELISTED
NuVasive, Inc.
NUVA
$4.27M 0.15%
75,760
-1,622
-2% -$79.8K
TTEK icon
114
Tetra Tech
TTEK
$9.01B
$4.25M 0.15%
183,585
-139,915
-43% -$3.15M
SKY icon
115
Champion Homes
SKY
$5.04B
$4.21M 0.15%
136,095
-6,051
-4% -$178K
IWO icon
116
iShares Russell 2000 Growth ETF
IWO
$14.9B
$4.2M 0.15%
14,645
+13,332
+1,015% +$3.4M
PRVB
117
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$4.19M 0.15%
247,116
+16,243
+7% +$243K
INOV
118
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$4.18M 0.15%
+229,941
New +$4.91M
LNN icon
119
Lindsay Corp
LNN
$1.17B
$4.16M 0.15%
32,359
-11,351
-26% -$1.3M
WW
120
DELISTED
WW International
WW
$4.12M 0.14%
168,659
+34,463
+26% +$896K
MRCY icon
121
Mercury Systems
MRCY
$6.54B
$4.07M 0.14%
46,176
-16,341
-26% -$1.24M
PRMW
122
DELISTED
Primo Water Corporation
PRMW
$3.98M 0.14%
253,680
-89,410
-26% -$1.32M
GFF icon
123
Griffon
GFF
$4.72B
$3.97M 0.14%
+194,917
New +$4.19M
QNST icon
124
QuinStreet
QNST
$1.24B
$3.9M 0.14%
182,094
-54,653
-23% -$997K
SPWR
125
DELISTED
SunPower Corporation Common Stock
SPWR
$3.8M 0.13%
148,295
-97,994
-40% -$1.98M

Similar funds

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.